Home / News

2026-02-27: Keythera’s KF-0210 Phase 2a Study Accepted for Podium Presentat...

Suzhou, China, February 27, 2026 — Keythera (Suzhou) Biopharmaceuticals Co., Ltd. (“Keythera”) today announced that the abstract of its exploratory ...

2021-03-22

Keythera announced the completion of the first patient first dosing in Phase I clinical trial of KF-0210 and secured a Series A+ investment of 100 million RMB

Keythera (Suzhou) Biopharmaceuticals Co., Ltd. (referred to as "Keythera"), an innovative drug development company, announced the administration of the first patient in the Phase I clinical trial of KF-0210 (NCT04713891) in Australia. ...

More >>

2020-12-10

Keythera won New Bud Award 2020 Venture Top 50

After 8-month evaluation, the 2020 Venture Top 50 list was finally unveiled. Richland Equities series enterprise Keythera Biopharmaceuticals won the honor on the top 50 New Bud List!...

More >>

2020-09-28

Keythera completed RMB 100M Series A financing

Recently, Keythera (Suzhou) Biopharmaceutical Co., Ltd., an innovative drug research and development enterprise, announced the completion of a Series A financing of nearly RMB 100 million....

More >>